Insider · CIK 0001257241

Durus Capital Management NA LLC

CIK 0001257241 Name as filed on the most recent filing

Filed as Durus Capital Management NA LLC (50)

1,473 transaction lines · from 50 filings · filed 2003-07-31 to 2003-07-31 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-28 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-28 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2003-04-14 P, Open-market purchase Aksys LtdAKSY 76,405, acquired Open Form 4 filing 0001005477-03-002889
2003-04-14 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 77,049, acquired Open Form 4 filing 0001005477-03-002851
2003-04-11 P, Open-market purchase Aksys LtdAKSY 201,361, acquired Open Form 4 filing 0001005477-03-002889
2003-04-11 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 79,410, acquired Open Form 4 filing 0001005477-03-002851
2003-04-10 P, Open-market purchase Aksys LtdAKSY 125,198, acquired Open Form 4 filing 0001005477-03-002889
2003-04-10 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 193,311, acquired Open Form 4 filing 0001005477-03-002851
2003-04-09 P, Open-market purchase Aksys LtdAKSY 132,613, acquired Open Form 4 filing 0001005477-03-002889
2003-04-09 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 2 lines 369,650, acquired Open Form 4 filing 0001005477-03-002851
2003-04-08 P, Open-market purchase Aksys LtdAKSY 416,911, acquired Open Form 4 filing 0001005477-03-002889
2003-04-08 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 451,511, acquired Open Form 4 filing 0001005477-03-002851
2003-04-07 P, Open-market purchase Aksys LtdAKSY 664,789, acquired Open Form 4 filing 0001005477-03-002889
2003-04-07 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 94,412, acquired Open Form 4 filing 0001005477-03-002851
2003-04-04 P, Open-market purchase Aksys LtdAKSY 617,461, acquired Open Form 4 filing 0001005477-03-002889
2003-04-04 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 880,789, acquired Open Form 4 filing 0001005477-03-002851
2003-04-03 P, Open-market purchase Aksys LtdAKSY 2 lines 551,464, acquired Open Form 4 filing 0001005477-03-002889
2003-04-03 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 4 lines 920,583, acquired Open Form 4 filing 0001005477-03-002850
2003-04-02 P, Open-market purchase Aksys LtdAKSY 3 lines 1,046,365, acquired Open Form 4 filing 0001005477-03-002889
2003-04-02 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 1,617,692, acquired Open Form 4 filing 0001005477-03-002850
2003-04-01 P, Open-market purchase Aksys LtdAKSY 602,783, acquired Open Form 4 filing 0001005477-03-002889
2003-04-01 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 553,867, acquired Open Form 4 filing 0001005477-03-002850
2003-03-31 P, Open-market purchase Aksys LtdAKSY 738,171, acquired Open Form 4 filing 0001005477-03-002889
2003-03-31 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 2 lines 337,637, acquired Open Form 4 filing 0001005477-03-002850
2003-03-28 P, Open-market purchase Aksys LtdAKSY 329,648, acquired Open Form 4 filing 0001005477-03-002889
2003-03-28 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 90,710, acquired Open Form 4 filing 0001005477-03-002850
2003-03-27 P, Open-market purchase Aksys LtdAKSY 2 lines 404,627, acquired Open Form 4 filing 0001005477-03-002889
2003-03-27 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 359,501, acquired Open Form 4 filing 0001005477-03-002850
2003-03-26 P, Open-market purchase Aksys LtdAKSY 489,426, acquired Open Form 4 filing 0001005477-03-002889
2003-03-26 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 2 lines 995,489, acquired Open Form 4 filing 0001005477-03-002850
2003-03-25 P, Open-market purchase Aksys LtdAKSY 465,869, acquired Open Form 4 filing 0001005477-03-002889
2003-03-25 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 596,046, acquired Open Form 4 filing 0001005477-03-002850
2003-03-24 P, Open-market purchase Aksys LtdAKSY 502,383, acquired Open Form 4 filing 0001005477-03-002889
2003-03-24 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 541,519, acquired Open Form 4 filing 0001005477-03-002850
2003-03-21 P, Open-market purchase Aksys LtdAKSY 2 lines 1,006,179, acquired Open Form 4 filing 0001005477-03-002889
2003-03-21 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 2 lines 252,400, acquired Open Form 4 filing 0001005477-03-002850
2003-03-20 P, Open-market purchase Aksys LtdAKSY 2 lines 724,621, acquired Open Form 4 filing 0001005477-03-002889
2003-03-20 P, Open-market purchase Esperion Therapeutics Inc/MIESPR 2 lines 419,778, acquired Open Form 4 filing 0001005477-03-002850

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. DURUS CAPITAL MANAGEMENT NA LLC, insider transactions. Retrieved 2026-08-28 from https://ebomi.com/insider/0001257241

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.